3.3. Repeated T22-DITOX-H6 or T22-PE24-H6 Treatment Inhibit Tumor Growth and Increases Survival without Systemic Toxicity in a CXCR4+ AN3CA Subcutaneous CE Model. The gene discussed is CXCR4; the disease is neoplasm.